Coviden has been busy lately. In the last month or so, we’ve covered three pieces of news related to the Irish medical device company, including its OneShot renal denervation system, Endo GIA radial reload colon cutter/stapler and V-Loc knotless suturing technology.
Now, the company has announced the debut of the Nellcor SpO2 single parameter module for use with the Philips IntelliVue line of patient monitoring systems, including the MP40 through MP90 products and the MX 600, MX 700, and MX 800 monitors.
The module will be available in North America, Europe, and a number of other international markets. It uses the firm’s OxiMax pulse oximetry technology to monitor a patient’s respiratory function status.
Robert J. White, Coviden’s president of respiratory and monitoring solutions explains in a press release that the product’s broad compatibility enables it to be used “across all areas of the hospital, from the general care ward to critical care areas, such as the intensive care unit and neonatal care ward.”
The use of the pulse oximetry device with monitoring platforms provides clinicians with cardiac-based readings of SpO2 and pulse rate. This functionality supports its use in what the company’s chief medical officer, Scott Kelley, MD, describes as “challenging conditions” such as low perfusion.
The Nellcor OxiMax technology includes an alarm management feature to help clinicians distinguish between minor events and clinically significant fluctuations in desaturation.
Press release: Covidien Announces Global Launch of Nellcor™ SpO2 Module for Philips IntelliVue Patient Monitors…
